foxo4-dri senolytic peptide 2024 study

foxo4-dri senolytic peptide 2024 study FOXO4-DRI: Human Trial Status, Cancer Research & Data Frontiers | FOXO4-DRI regulates endothelial

Name: foxo4-dri senolytic peptide 2024 study FOXO4-DRI: Human Trial Status, Cancer Research & Data Frontiers | FOXO4-DRI regulates endothelial
Brand: equiscorp.hu
SKU: 68176105192
Price: 20.07 USD
Availability: InStock
Rating: 4.7443 (26 reviews)

Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Wikipedia Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Buy FOXO4 DRI Greece PharmaGrade.Store

SKU: 68176105192 · From equiscorp.hu

4.7

USD20.07 USD60.07

Pay in 4 interest-free payments of $5.02 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Recently, a mimetic peptide of TSP-1 called 4N1Ks has been developed as a senolytic therapy and confirm the high interest to investigate CD47 pathway in senescence 48

There are no reviews yet.

If you need a specific batch record, contact support before ordering

Metabolic biomarkers and neurodegeneration: a pathway Enrichment Analysis of Alzheimers Disease, Parkinsons Disease, and amyotrophic lateral sclerosis